doi: 10.3389/fonc.2024.1392375 Received 27 February 2024 Accepted 02 April 2024 Published 18 April 2024 Volume 14 - 2024 Edited by Karuna Rasineni, University of Nebraska Medical Center, United States Reviewed by Luigi Losco, University of Salerno, Italy Asher Rajkumar Rajan, University of Nebraska Medical Center, United States Updates Copyright 2024 Crowley, Brown, Gallagher and Dayan
Indeed, the presence of sarcopenia and obesity, as well as SO with its dual impact, contributes substantially to national and global healthcare expenditures and serves as a prognostic factor for the growing burden on public health [5, 6]
Direct GH injections present higher risk profiles due to their pharmacokinetics
These therapies can assist in improving antioxidant status, reducing oxidative stress, and supporting tissue repair processes